Literature DB >> 1926054

Strategies for the improvement of thrombolytic agents.

H R Lijnen, D Collen.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1926054

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  21 in total

1.  Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system.

Authors:  J F Liang; Y T Li; M E Connell; V C Yang
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Molecular basis of thrombolytic therapy.

Authors:  H R Lijnen; D Collen
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

Review 3.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

4.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

6.  A faster-acting and more potent form of tissue plasminogen activator.

Authors:  B A Keyt; N F Paoni; C J Refino; L Berleau; H Nguyen; A Chow; J Lai; L Peña; C Pater; J Ogez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Tissue-type plasminogen activator: a role for O-linked fucose.

Authors:  J U Baenziger
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro.

Authors:  Shaozheng Song; Xin Ge; Yaobin Cheng; Rui Lu; Ting Zhang; Baoli Yu; Xueqiao Ji; Zhengqiang Qi; Yao Rong; Yuguo Yuan; Yong Cheng
Journal:  Mol Biol Rep       Date:  2016-05-26       Impact factor: 2.316

9.  Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.

Authors:  M Yamada; T Horiuchi; T Oribe; S Yamamoto; I Sugie; P A Gentry
Journal:  Vet Res Commun       Date:  1997-02       Impact factor: 2.459

10.  39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.

Authors:  I Warshawsky; G Bu; A L Schwartz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.